← Studies & programmes
Myelin repairPhase 1 study in peopleStudy completed
Metformin in progressive MS: completed Phase 1, results awaited
Published by MyelinWatch:
Metformin PMS · The completed early Phase 1 study assessed metformin in people with primary or secondary progressive MS, focusing first on safety.
What is being studied
The completed early Phase 1 study assessed metformin in people with primary or secondary progressive MS, focusing first on safety.
Research stage
Phase 1 study in people
Completed; results have not yet been published
What we know so far
The study is complete, but public results have not yet been published. Its findings cannot be judged from the information currently available.
What this means for patients today
This small early study did not establish benefit. Metformin is not an approved myelin-repair treatment on this evidence.
- Treatment or approach
- Metformin • primary or secondary progressive MS
- How it is intended to work
- Uses metformin to influence the cell processes involved in repair
- Published by MyelinWatch
- Last substantive MyelinWatch update